Search results
Clearmind develops novel psychedelic medicines to solve widespread—yet under-served—health problems. With a strong medical management and IP-protected treatments, we can better the lives of millions.
- Our Team
Our Team - Clearmind Medicine
- News Releases
Clearmind develops novel psychedelic medicines to solve...
- Science and IP
Clearmind’s novel treatment candidates are backed by...
- Our Team
Nov 17, 2022 · Clearmind Medicine Inc. announces the closing of a US$7.5 million public offering and its uplisting to the Nasdaq Capital Market. The company is developing novel psychedelic-derived therapeutics for alcohol use disorder and other health problems.
Clearmind develops novel psychedelic medicines to solve widespread—yet under-served—health problems. With a strong medical management and IP-protected treatments, we can better the lives of millions.
Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally.
May 7, 2024 · Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and...
Jan 10, 2024 · Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health...
Feb 20, 2024 · Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems ...